company background image
NTI

Neurotech International ASX:NTI Stock Report

Last Price

AU$0.084

Market Cap

AU$67.8m

7D

-5.6%

1Y

44.8%

Updated

30 Nov, 2022

Data

Company Financials
NTI fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

NTI Stock Overview

Neurotech International Limited, together with its subsidiaries, engages in the research, design, development, and manufacture of medical devices and solutions in Australia.

Neurotech International Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Neurotech International
Historical stock prices
Current Share PriceAU$0.084
52 Week HighAU$0.13
52 Week LowAU$0.044
Beta2.24
1 Month Change-15.15%
3 Month Change-15.15%
1 Year Change44.83%
3 Year Change342.11%
5 Year Change-58.00%
Change since IPO-70.53%

Recent News & Updates

Is Neurotech International (ASX:NTI) In A Good Position To Deliver On Growth Plans?

Oct 06
Is Neurotech International (ASX:NTI) In A Good Position To Deliver On Growth Plans?

Recent updates

Is Neurotech International (ASX:NTI) In A Good Position To Deliver On Growth Plans?

Oct 06
Is Neurotech International (ASX:NTI) In A Good Position To Deliver On Growth Plans?

Here's Why We're Watching Neurotech International's (ASX:NTI) Cash Burn Situation

May 18
Here's Why We're Watching Neurotech International's (ASX:NTI) Cash Burn Situation

We're Not Very Worried About Neurotech International's (ASX:NTI) Cash Burn Rate

Dec 21
We're Not Very Worried About Neurotech International's (ASX:NTI) Cash Burn Rate

Neurotech International (ASX:NTI) Is In A Good Position To Deliver On Growth Plans

Sep 04
Neurotech International (ASX:NTI) Is In A Good Position To Deliver On Growth Plans

Need To Know: Neurotech International Limited (ASX:NTI) Insiders Have Been Selling Shares

Dec 08
Need To Know: Neurotech International Limited (ASX:NTI) Insiders Have Been Selling Shares

Shareholder Returns

NTIAU Medical EquipmentAU Market
7D-5.6%2.7%0.2%
1Y44.8%-7.7%-2.7%

Return vs Industry: NTI exceeded the Australian Medical Equipment industry which returned -7.7% over the past year.

Return vs Market: NTI exceeded the Australian Market which returned -2.7% over the past year.

Price Volatility

Is NTI's price volatile compared to industry and market?
NTI volatility
NTI Average Weekly Movement11.9%
Medical Equipment Industry Average Movement9.8%
Market Average Movement9.0%
10% most volatile stocks in AU Market15.9%
10% least volatile stocks in AU Market4.2%

Stable Share Price: NTI is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 12% a week.

Volatility Over Time: NTI's weekly volatility (12%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2016n/aPeter James Griffithshttps://www.neurotechinternational.com

Neurotech International Limited, together with its subsidiaries, engages in the research, design, development, and manufacture of medical devices and solutions in Australia. The company is focused on development and commercializing Mente platform, a platform technology to monitor and play role in home-based therapies. Its product includes Mente Autism for the diagnosis and treatment of autism.

Neurotech International Limited Fundamentals Summary

How do Neurotech International's earnings and revenue compare to its market cap?
NTI fundamental statistics
Market CapAU$67.78m
Earnings (TTM)-AU$3.36m
Revenue (TTM)AU$607.62k

112.0x

P/S Ratio

-20.2x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
NTI income statement (TTM)
RevenueAU$607.62k
Cost of RevenueAU$34.05k
Gross ProfitAU$573.57k
Other ExpensesAU$3.94m
Earnings-AU$3.36m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.0042
Gross Margin94.40%
Net Profit Margin-553.35%
Debt/Equity Ratio0.0%

How did NTI perform over the long term?

See historical performance and comparison